1-(3-cyanophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid, 98%, 1g

5-CHLORO-N-((2S,3R)-4-((3S,4R)-3,4-DIHYDROXYPYRROLIDIN-1-YL)-3-HYDROXY-4-OXO-1-PHENYLBUTAN-2-YL)-1H-INDOLE-2-CARBOXAMIDE, 95%, 25mg

1-(3-phenylpropyl)-1H-pyrazol-3-amine, 95.0%, 5g

3-Cyclobutyl-1H-pyrazolo[3,4-b]pyridin-5-amine, >95%, 250mg

ethyl 4-(cyanosulfanyl)-5-(furan-2-amido)-3-methylthiophene-2-carboxylate, 95.0%, 1g

Recipiente de reacción con brida plana cilíndrico, graduado (2) Fondo plano, DN 200, 315 mm, Altura, 440 mm, 1 Pieza

2-OXA-8-AZASPIRO[4.5]DECANE HEMIOXALATE, 95.0%, 10g

4,7,10,13,16,19-Hexaoxadocosa-1,21-diyne, 1g

6-Fluoroisobenzofuran-1(3H)-one, 95.0%, 100mg

1-(methoxyacetyl)-1,2,3,4-tetrahydroquinolin-7-amine, 95.0%, 500mg

Benzooxazole-2-thiol, 99.00%, 100g

4-(furan-2-carbonyl)-8-propyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

(4-FLUOROAZEPAN-4-YL)METHANOL HCL, 95.0%, 250mg